Success Metrics

Clinical Success Rate
50.0%

Based on 3 completed trials

Completion Rate
50%(3/6)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
3(27%)

Phase Distribution

Ph not_applicable
4
36%
Ph phase_4
3
27%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution7 total trials
Phase 4Post-market surveillance
3(42.9%)
N/ANon-phased studies
4(57.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

42.9%

3 of 7 finished

Non-Completion Rate

57.1%

4 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Completed(3)
Terminated(4)
Other(4)

Detailed Status

unknown4
Terminated3
Completed3
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
50.0%
Most Advanced
Phase 4

Trials by Phase

Phase 43 (42.9%)
N/A4 (57.1%)

Trials by Status

terminated327%
completed327%
withdrawn19%
unknown436%

Recent Activity

0 active trials
Showing 5 of 11
terminated

Evaluation of Effectiveness and Safety of Bioresorbable Vascular Scaffold in Routine Clinical Practice

NCT02622100
terminated

IRIS-BVS AMI Registry

NCT02699671
withdrawn

Thrombogenicity Assessment in Patients Treated With Bioresorbable Vascular Scaffolds

NCT03033862
unknownnot_applicable

A Prospective, Randomized Trial of BVS Veruss EES in Patients Undergoing Coronary Stenting for Myocardial Infarction

NCT01942070
completedphase_4

Comparison of the Vasomotor Function and Myocardial Flow in Patients Treated With Bioresorbable and Metallic Stents at 1 Year

NCT02738658
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT02622100

Evaluation of Effectiveness and Safety of Bioresorbable Vascular Scaffold in Routine Clinical Practice

Terminated
NCT02699671

IRIS-BVS AMI Registry

Terminated
NCT03033862

Thrombogenicity Assessment in Patients Treated With Bioresorbable Vascular Scaffolds

Withdrawn
NCT01942070Not Applicable

A Prospective, Randomized Trial of BVS Veruss EES in Patients Undergoing Coronary Stenting for Myocardial Infarction

Unknown
NCT02738658Phase 4

Comparison of the Vasomotor Function and Myocardial Flow in Patients Treated With Bioresorbable and Metallic Stents at 1 Year

Completed
NCT03180931

Independent OCT Registry on Very Late Bioresorbable Scaffold Thrombosis

Completed
NCT02672878Phase 4

Restenosis Intrastent: Bioresorbable Vascular Scaffolds Treatment (RIBS VI)

Unknown
NCT02319733Not Applicable

Plaque Stabilization and Restoration by Bioresorbable Vascular Scaffold

Terminated
NCT01876589Not Applicable

Impact of Vascular Reparative Therapy on Vasomotor Function and Myocardial Perfusion:a Randomized H215O PET/CT Study

Unknown
NCT02771288Not Applicable

Safety and Vascular Remodelling After BVS Implantation for Stenotic or Occluded Lesions in Children and Young Adults With KD.

Unknown
NCT02151929Phase 4

Bioresorbable Vascular Scaffold in Patients With Myocardial Infarction

Completed

All 11 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
11